BioCardia, Inc. Income Statement
BCDA|3 years of annual SEC 10-K data (FY2011-FY2017)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 3 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$479,000
FY2017
Gross Profit
N/A
FY2017
Operating Income
-$12M
FY2017
Net Income
-$12M
FY2017
BioCardia, Inc. reported $479,000 in revenue and $12M in net loss for FY2017. Revenue has grown at a 84.9% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -110.6% ROE
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2011 |
|---|---|---|---|
| Revenue | $479.0K | $576.0K | $12.0K |
| Cost of Revenue | $690.0K | $746.0K | $0 |
| Gross Profit | - | - | $12.0K |
| SG&A Expense | $6.4M | $4.1M | $630.0K |
| R&D Expense | $5.8M | $3.3M | - |
| Operating Income | -$12.4M | -$7.6M | -$618.0K |
| Interest Expense | $0 | $1.7M | - |
| Income Tax | $0 | $0 | - |
| Net Income | -$12.3M | -$10.3M | $9.7M |
| EPS (Diluted) | -$4.29 | -$0.36 | -$0.05 |
| Shares Outstanding | 38.1M | 18.9M | 230.3M |
| Gross Margin | - | - | 100.0% |
| Operating Margin | -2589.8% | -1320.8% | -5150.0% |
| Profit Margin | -2569.5% | -1789.9% | 80516.7% |